We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




System Automates and Simplifies Food Testing

By HospiMedica staff writers
Posted on 28 Jun 2006
A new automated system detects food contaminants, such as pesticides, dyes, mole-related toxins, and chemical and antibiotic residues.

Cliquid software for food testing increases the precision of food-contaminant testing while simplifying the process. More...
The system was produced by Applied Biosystems (Foster City, CA, USA), an Applera Corporation (Norwalk, CT, USA) business, and its joint venture partner MDS Sciex (Concord, Canada). The system enables testing labs, food producers, and manufacturers to more quickly and thoroughly identify a wide range of contaminants. Cliquid software has been designed to bring point-and-check functionality to Applied Biosystems/MDS Sciex's high performance liquid chromatography/mass spectrometry/mass spectrometry (LC/MS/MS) systems.

Dr. Philippe Guy of the Quality and Safety Assurance Department at the Nestlé Research Centre (Lausanne, Switzerland) is one of the collaborators who helped to define the requirements for LC/MS/MS analysis in the food testing market. "The Cliquid software provides research facilities, like ours at Nestlé with the ability to deploy new validated methods, instrument tests, and reporting requirements to our regional laboratories,” said Dr. Guy. "Indeed, with such a simple interface and workflow, laboratory personnel can adopt LC/MS/MS techniques and rapidly produce high quality standardized results.”

Mass spectrometry offers high levels of sensitivity by detecting molecules in various substances. Applied Biosystems/MDS Sciex is applying this technology to food testing through an easy-to-use software interface, and food companies and public health testing labs can use this solution without the need for extra resources or special training in mass spectrometry. The pre-configured testing methods and flexibility of the software allow every testing facility to develop systematic testing protocols. Results are captured in automatically generated reports that can be customized to meet quality controls, regulatory, and laboratory requirements worldwide.

Cliquid software for food testing will be available as a stand-alone software package or as part of a complete testing system that includes the API 3200 or 3200 Q Trap mass spectrophotometers, coupled with an HPLC system and starter kit.



Related Links:
Applied Biosystems

Gold Member
12-Channel ECG
CM1200B
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Multi-Chamber Washer-Disinfector
WD 390
Digital Radiography System (Ceiling Free)
Digix CF Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: New findings show that chemotherapy plus immunotherapy before surgery produced greater tumor destruction than immunotherapy alone in head and neck cancer patients (Image Credit: Adobe Stock)

Combination Therapy Before Surgery Drives Stronger Tumor Reduction in Head and Neck Cancer

Patients with head and neck cancer who are scheduled for surgery often face a waiting period with limited treatment, creating an opportunity to reduce viable tumor burden before the operation.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.